| scholarly article | Q13442814 |
| P50 | author | Eric Lander | Q970550 |
| Jeffrey M. Drazen | Q4188546 | ||
| David Altshuler | Q5230746 | ||
| Lyle J. Palmer | Q30512610 | ||
| Stacey Gabriel | Q32649203 | ||
| Ross Lazarus | Q56440832 | ||
| Erwin W. Gelfand | Q81699397 | ||
| Michael E Wechsler | Q89490244 | ||
| Edwin K Silverman | Q89513458 | ||
| Kelan G Tantisira | Q94646817 | ||
| Elliot Israel | Q124853372 | ||
| P2093 | author name string | Stephen B Liggett | |
| Scott T Weiss | |||
| Lanny J Rosenwasser | |||
| Eric S Silverman | |||
| Stephen Lake | |||
| Brent Richter | |||
| P2860 | cites work | A New Statistical Method for Haplotype Reconstruction from Population Data | Q27860495 |
| Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group | Q28371563 | ||
| Score tests for association between traits and haplotypes when linkage phase is ambiguous | Q29616281 | ||
| Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates | Q30504140 | ||
| A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. | Q30882915 | ||
| The genomic organization of the human corticotropin-releasing factor type-1 receptor | Q32012085 | ||
| Presentation of new GINA guidelines for paediatrics. The Global Initiative on Asthma | Q33940555 | ||
| Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression | Q34095571 | ||
| The CRF peptide family and their receptors: yet more partners discovered | Q34112872 | ||
| Molecular biology of the CRH receptors-- in the mood | Q34241372 | ||
| Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo | Q34241379 | ||
| Heterogeneity of therapeutic responses in asthma | Q34255472 | ||
| Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach | Q34428395 | ||
| Minimal haplotype tagging | Q35814348 | ||
| Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial | Q43614612 | ||
| Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial | Q43614613 | ||
| Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system | Q43800961 | ||
| Significant variability in response to inhaled corticosteroids for persistent asthma | Q43920193 | ||
| A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children | Q44459452 | ||
| A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. | Q53352816 | ||
| Long-term effects of budesonide or nedocromil in children with asthma. | Q53809666 | ||
| The Childhood Asthma Management Program (CAMP) | Q57072321 | ||
| Haplotype tagging for the identification of common disease genes | Q59200321 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 1353-1359 | |
| P577 | publication date | 2004-05-05 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids | |
| P478 | volume | 13 |
| Q86419589 | A Mutagenic Primer Assay for Genotyping of the CRHR1 Gene Rare Variant rs1876828 (A/G) in Asians: A Cost-Effective SNP Typing |
| Q33763915 | A methodology to establish a database to study gene environment interactions for childhood asthma |
| Q87146866 | A novel genotyping method for detection of the CRHR1 (rs1396862: C>T) gene variation among North Indian population |
| Q36734679 | Acceptance of Asthma Pharmacogenetic Study by Children and Adults |
| Q38930984 | Addressing corticosteroid insensitivity in adults with asthma |
| Q88091392 | Adrenal insufficiency and ICS: genetics takes a breath |
| Q24648561 | African Americans with asthma: genetic insights |
| Q37647201 | Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects |
| Q58862200 | Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma |
| Q34348095 | Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans |
| Q35525863 | Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma |
| Q61811224 | Association of genetic variants with level of asthma control in the Arab population |
| Q48711366 | Association of hypothalamic-pituitary-adrenal axis-related polymorphisms with stress in asthmatic children on inhaled corticosteroids. |
| Q38542847 | Asthma Pharmacogenomics: 2015 Update |
| Q39858503 | Asthma control and future asthma-related morbidity in inner-city asthmatic children |
| Q36734803 | Asthma from a pharmacogenomic point of view |
| Q36622292 | Asthma genetics and personalised medicine |
| Q37150901 | Asthma genetics: personalizing medicine |
| Q35076452 | Asthma pharmacogenetics and the development of genetic profiles for personalized medicine |
| Q37224170 | Asthma treatment outcome in adults is associated with rs9910408 in TBX21 gene |
| Q83943731 | Asthma treatment outcome in children is associated with vascular endothelial growth factor A (VEGFA) polymorphisms |
| Q98619726 | CASTER: Cross-Sectional Asthma STEroid Response Measurement |
| Q56767466 | CRHR1 Gene SNPs and Response to Systemic Corticosteroids in Indian Asthmatic Children During Acute Exacerbation |
| Q34662042 | Can certain genotypes predispose to poor asthma control in children? A pharmacogenetic study of 9 candidate genes in children with difficult asthma. |
| Q35575815 | Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma |
| Q36989836 | Clinical pharmacogenetics in pediatric patients |
| Q36450756 | Concordance of DMET plus genotyping results with those of orthogonal genotyping methods |
| Q37202607 | Creating and evaluating genetic tests predictive of drug response |
| Q92675394 | DNA methylation is associated with inhaled corticosteroid response in persistent childhood asthmatics |
| Q37704461 | Determinants Of Oral corticosteroid Responsiveness in Wheezing Asthmatic Youth (DOORWAY): protocol for a prospective multicentre cohort study of children with acute moderate-to-severe asthma exacerbations |
| Q44202329 | Effect of tumor necrosis factor-α antagonism in asthma: a meta-analysis of the published literature |
| Q60307179 | Effects of Glucocorticoid-Induced Transcript 1 Gene Deficiency on Glucocorticoid Activation in Asthmatic Mice |
| Q47678283 | Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review |
| Q34388432 | Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma |
| Q45713818 | Functional polymorphism in CTLA4 gene influences the response to therapy with inhaled corticosteroids in Slovenian children with atopic asthma. |
| Q37649812 | GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma |
| Q47642629 | GLCCI1 rs37973: A potential genetic predictor of therapeutic response to inhaled corticosteroids in Chinese asthma patients. |
| Q28475658 | Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis |
| Q30810336 | Gene variants in noncoding regions and their possible consequences |
| Q60913194 | Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review |
| Q54454694 | Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation. |
| Q37997823 | Genetic basis for personalized medicine in asthma |
| Q40292888 | Genetic factors in the treatment of bronchial asthma |
| Q37217063 | Genetic mapping with multiple levels of phenotypic information reveals determinants of lymphocyte glucocorticoid sensitivity |
| Q34342451 | Genetic polymorphisms and associated susceptibility to asthma |
| Q37523908 | Genetic predictors of response to therapy in childhood asthma |
| Q64981123 | Genetic variation in CRHR1 is associated with short-term respiratory response to corticosteroids in preterm infants at risk for bronchopulmonary dysplasia. |
| Q39098740 | Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment |
| Q35556785 | Genetics of allergic diseases |
| Q36201283 | Genetics of asthma susceptibility and severity |
| Q37448915 | Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications |
| Q35665779 | Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma |
| Q36052666 | Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus |
| Q36886258 | Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma |
| Q33809390 | Global analysis of the impact of environmental perturbation on cis-regulation of gene expression |
| Q34746767 | H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence |
| Q36075209 | How pharmacogenomics will play a role in the management of asthma |
| Q33236283 | Identification of rat lung--prominent genes by a parallel DNA microarray hybridization |
| Q38181015 | Immunobiology of critical pediatric asthma |
| Q30444397 | Immunoglobulin E-mediated airway inflammation is active in most patients with asthma |
| Q37795581 | Immunomodulators for asthma |
| Q37419522 | Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma |
| Q34120964 | In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma. |
| Q37619394 | Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics |
| Q35056188 | Inhaled corticosteroids and secondary adrenal insufficiency |
| Q58118485 | Integrative approach identifies corticosteroid response variant in diverse populations with asthma |
| Q26861541 | Integrative systems biology approaches in asthma pharmacogenomics |
| Q42105299 | Inter-ethnic differences in lymphocyte sensitivity to glucocorticoids reflect variation in transcriptional response |
| Q26864177 | Is personalized medicine achievable in obstetrics? |
| Q34363640 | Key role of CRF in the skin stress response system |
| Q36934378 | Magnesium nebulization utilization in management of pediatric asthma (MagNUM PA) trial: study protocol for a randomized controlled trial. |
| Q36924300 | Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids |
| Q37776695 | Maternal ethnicity influences on neonatal respiratory outcomes after antenatal corticosteroid use for anticipated preterm delivery |
| Q35931560 | Measuring the corticosteroid responsiveness endophenotype in asthmatic patients |
| Q33502728 | Monitoring asthma control using claims data and patient-reported outcomes measures |
| Q36879966 | Neonatal Genetic Variation in Steroid Metabolism and Key Respiratory Function Genes and Perinatal Outcomes in Single and Multiple Courses of Corticosteroids |
| Q36433595 | Overview of the pharmacogenetics of asthma treatment. |
| Q34582222 | Patterns of inhaled corticosteroid use and asthma control in the Childhood Asthma Management Program Continuation Study |
| Q38162869 | Pediatric perspective on pharmacogenomics. |
| Q38065106 | Personalised medicine and asthma diagnostics/management |
| Q64923655 | Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy. |
| Q48220346 | Pharmacogenetic and pharmacogenomic considerations of asthma treatment. |
| Q36026011 | Pharmacogenetic approaches in the treatment of asthma. |
| Q35889605 | Pharmacogenetics and drug development: the path to safer and more effective drugs |
| Q33781272 | Pharmacogenetics and individualizing drug treatment during pregnancy |
| Q38851479 | Pharmacogenetics and interstitial lung disease |
| Q37425660 | Pharmacogenetics and the development of personalized approaches for combination therapy in asthma |
| Q38646972 | Pharmacogenetics and the treatment of asthma |
| Q35038056 | Pharmacogenetics in drug development |
| Q85532119 | Pharmacogenetics of Asthma |
| Q82941102 | Pharmacogenetics of asthma |
| Q46107352 | Pharmacogenetics of asthma controller treatment |
| Q38121970 | Pharmacogenetics of chronic obstructive pulmonary disease |
| Q33706037 | Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities |
| Q23919667 | Pharmacogenetics, pharmacogenomics, and individualized medicine |
| Q33940766 | Pharmacogenomic approaches to asthma treatment |
| Q34436523 | Pharmacogenomics of pediatric asthma |
| Q36658763 | Pharmacogenomics: challenges and opportunities |
| Q34074486 | Pharmacogenomics: novel loci identification via integrating gene differential analysis and eQTL analysis. |
| Q24814595 | Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma |
| Q36210219 | Predicting inhaled corticosteroid response in asthma with two associated SNPs |
| Q33581533 | Predicting response to short-acting bronchodilator medication using Bayesian networks |
| Q37352280 | Predictors of poor response during asthma therapy differ with definition of outcome |
| Q36874335 | Recent development in pharmacogenomics: from candidate genes to genome-wide association studies. |
| Q28079307 | Research advances in gene polymorphisms in biological pathways of drugs for asthma |
| Q38853320 | Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma |
| Q37140629 | Role of biomarkers in understanding and treating children with asthma: towards personalized care |
| Q37762863 | Role of genetic polymorphisms in therapeutic response to anti-asthma therapy |
| Q37353978 | Safety and efficacy of inhaled corticosteroids (ICS) in children with asthma |
| Q36108246 | Severe asthma in children. |
| Q42600043 | Significant linkage to airway responsiveness on chromosome 12q24 in families of children with asthma in Costa Rica |
| Q51579824 | Steroid Pathway Genes and Neonatal Respiratory Distress After Betamethasone Use in Anticipated Preterm Birth. |
| Q37896808 | Steroid responsiveness and wheezing phenotypes |
| Q34613768 | Stress and asthma: novel insights on genetic, epigenetic, and immunologic mechanisms |
| Q33768488 | Stress-induced differences in primary and secondary resistance against bacterial sepsis corresponds with diverse corticotropin releasing hormone receptor expression by pulmonary CD11c+ MHC II+ and CD11c- MHC II+ APCs |
| Q50151574 | Systems biology and in vitro validation identifies FAM129A as asthma steroid response modulator. |
| Q36675485 | Targeted interventions for difficult-to-treat asthma |
| Q36538896 | The Childhood Asthma Management Program (CAMP): Contributions to the Understanding of Therapy and the Natural History of Childhood Asthma |
| Q26744623 | The Therapeutic Potential of Targeting Cytokine Alarmins to Treat Allergic Airway Inflammation |
| Q30460358 | The cochlear CRF signaling systems and their mechanisms of action in modulating cochlear sensitivity and protection against trauma |
| Q37875785 | The critically ill asthmatic--from ICU to discharge |
| Q36245776 | The future of microarray technology: networking the genome search |
| Q35051364 | The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids |
| Q35923045 | The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. |
| Q36641361 | The impact of glucocorticoid polymorphisms on markers of neonatal respiratory disease after antenatal betamethasone administration |
| Q64903516 | The impact of pharmacogenetics in the treatment of allergic disease and asthma. |
| Q30474734 | The mouse cochlea expresses a local hypothalamic-pituitary-adrenal equivalent signaling system and requires corticotropin-releasing factor receptor 1 to establish normal hair cell innervation and cochlear sensitivity |
| Q40314962 | The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial |
| Q35819993 | The pharmacogenetics and pharmacogenomics of asthma therapy |
| Q37343578 | The pharmacogenetics of asthma treatment |
| Q36752662 | The pharmacogenetics research network: from SNP discovery to clinical drug response. |
| Q33669054 | The role of pharmacogenomics in improving the management of asthma |
| Q47718997 | Treatment response heterogeneity in asthma: the role of genetic variation |
| Q40165160 | Using HapMap tools in pharmacogenomic discovery: the thiopurine methyltransferase polymorphism |
| Q79777678 | [Asthma genetic factors] |
Search more.